nodes	percent_of_prediction	percent_of_DWPC	metapath
Ephedrine—Pseudoephedrine—NFATC1—osteoporosis	0.0252	0.753	CrCbGaD
Ephedrine—Confusional state—Calcium Acetate—osteoporosis	0.00666	0.00766	CcSEcCtD
Ephedrine—Anorexia—Calcium Acetate—osteoporosis	0.0063	0.00725	CcSEcCtD
Ephedrine—Lightheadedness—Conjugated Estrogens—osteoporosis	0.00622	0.00715	CcSEcCtD
Ephedrine—Hypertension—Ergocalciferol—osteoporosis	0.00617	0.0071	CcSEcCtD
Ephedrine—Dysuria—Estropipate—osteoporosis	0.00617	0.0071	CcSEcCtD
Ephedrine—Hallucination—Etidronic acid—osteoporosis	0.00608	0.00699	CcSEcCtD
Ephedrine—Irritability—Ethinyl Estradiol—osteoporosis	0.00591	0.0068	CcSEcCtD
Ephedrine—Decreased appetite—Calcium Acetate—osteoporosis	0.00574	0.00661	CcSEcCtD
Ephedrine—Pain—Calcium Acetate—osteoporosis	0.00565	0.0065	CcSEcCtD
Ephedrine—Psychotic disorder—Pamidronate—osteoporosis	0.0056	0.00644	CcSEcCtD
Ephedrine—Anorexia—Ergocalciferol—osteoporosis	0.00556	0.0064	CcSEcCtD
Ephedrine—Blood pressure increased—Estradiol—osteoporosis	0.00556	0.0064	CcSEcCtD
Ephedrine—Sweating—Raloxifene—osteoporosis	0.00546	0.00629	CcSEcCtD
Ephedrine—Feeling abnormal—Calcium Acetate—osteoporosis	0.00545	0.00626	CcSEcCtD
Ephedrine—Sweating—Ibandronate—osteoporosis	0.00541	0.00622	CcSEcCtD
Ephedrine—Etomidate—CYP19A1—osteoporosis	0.00531	0.159	CrCbGaD
Ephedrine—Muscle spasms—Etidronic acid—osteoporosis	0.00511	0.00588	CcSEcCtD
Ephedrine—Angina pectoris—Risedronate—osteoporosis	0.00508	0.00584	CcSEcCtD
Ephedrine—Decreased appetite—Ergocalciferol—osteoporosis	0.00507	0.00584	CcSEcCtD
Ephedrine—Dysuria—Ethinyl Estradiol—osteoporosis	0.005	0.00575	CcSEcCtD
Ephedrine—Pain—Ergocalciferol—osteoporosis	0.00499	0.00574	CcSEcCtD
Ephedrine—Irritability—Conjugated Estrogens—osteoporosis	0.00482	0.00554	CcSEcCtD
Ephedrine—Asthenia—Calcium Acetate—osteoporosis	0.00474	0.00545	CcSEcCtD
Ephedrine—Tension—Estropipate—osteoporosis	0.00451	0.00519	CcSEcCtD
Ephedrine—Nervousness—Estropipate—osteoporosis	0.00447	0.00514	CcSEcCtD
Ephedrine—Arrhythmia—Calcitriol—osteoporosis	0.00443	0.0051	CcSEcCtD
Ephedrine—Muscle spasms—Estropipate—osteoporosis	0.00442	0.00509	CcSEcCtD
Ephedrine—Confusional state—Etidronic acid—osteoporosis	0.00437	0.00503	CcSEcCtD
Ephedrine—Dizziness—Calcium Acetate—osteoporosis	0.00437	0.00503	CcSEcCtD
Ephedrine—Muscle spasms—Alendronate—osteoporosis	0.00435	0.00501	CcSEcCtD
Ephedrine—Muscle spasms—Raloxifene—osteoporosis	0.00428	0.00493	CcSEcCtD
Ephedrine—Muscle spasms—Ibandronate—osteoporosis	0.00424	0.00488	CcSEcCtD
Ephedrine—Vomiting—Calcium Acetate—osteoporosis	0.0042	0.00483	CcSEcCtD
Ephedrine—Asthenia—Ergocalciferol—osteoporosis	0.00419	0.00482	CcSEcCtD
Ephedrine—Vertigo—Estropipate—osteoporosis	0.00413	0.00475	CcSEcCtD
Ephedrine—Dysuria—Conjugated Estrogens—osteoporosis	0.00408	0.00469	CcSEcCtD
Ephedrine—Vertigo—Alendronate—osteoporosis	0.00407	0.00468	CcSEcCtD
Ephedrine—Palpitations—Estropipate—osteoporosis	0.00406	0.00467	CcSEcCtD
Ephedrine—Vertigo—Raloxifene—osteoporosis	0.004	0.0046	CcSEcCtD
Ephedrine—Agitation—Calcitriol—osteoporosis	0.00397	0.00456	CcSEcCtD
Ephedrine—Vertigo—Ibandronate—osteoporosis	0.00396	0.00456	CcSEcCtD
Ephedrine—Nausea—Calcium Acetate—osteoporosis	0.00393	0.00452	CcSEcCtD
Ephedrine—Anxiety—Estropipate—osteoporosis	0.0039	0.00449	CcSEcCtD
Ephedrine—Palpitations—Ibandronate—osteoporosis	0.0039	0.00448	CcSEcCtD
Ephedrine—Chest pain—Alendronate—osteoporosis	0.00386	0.00444	CcSEcCtD
Ephedrine—Irritability—Estradiol—osteoporosis	0.00385	0.00443	CcSEcCtD
Ephedrine—Dyspepsia—Etidronic acid—osteoporosis	0.00382	0.00439	CcSEcCtD
Ephedrine—Hypertension—Ibandronate—osteoporosis	0.00381	0.00438	CcSEcCtD
Ephedrine—Chest pain—Raloxifene—osteoporosis	0.00379	0.00436	CcSEcCtD
Ephedrine—Chest pain—Ibandronate—osteoporosis	0.00375	0.00432	CcSEcCtD
Ephedrine—Anxiety—Ibandronate—osteoporosis	0.00374	0.0043	CcSEcCtD
Ephedrine—Arrhythmia—Risedronate—osteoporosis	0.00373	0.00429	CcSEcCtD
Ephedrine—Hypertension—Calcitriol—osteoporosis	0.00373	0.00429	CcSEcCtD
Ephedrine—Bradycardia—Zoledronate—osteoporosis	0.00369	0.00425	CcSEcCtD
Ephedrine—Chest pain—Calcitriol—osteoporosis	0.00368	0.00423	CcSEcCtD
Ephedrine—Anxiety—Calcitriol—osteoporosis	0.00366	0.00421	CcSEcCtD
Ephedrine—Muscle spasms—Ethinyl Estradiol—osteoporosis	0.00358	0.00412	CcSEcCtD
Ephedrine—Feeling abnormal—Etidronic acid—osteoporosis	0.00357	0.00411	CcSEcCtD
Ephedrine—Hyperhidrosis—Raloxifene—osteoporosis	0.00351	0.00404	CcSEcCtD
Ephedrine—Muscle spasms—Risedronate—osteoporosis	0.00349	0.00402	CcSEcCtD
Ephedrine—Hyperhidrosis—Ibandronate—osteoporosis	0.00348	0.004	CcSEcCtD
Ephedrine—Nausea—Ergocalciferol—osteoporosis	0.00347	0.00399	CcSEcCtD
Ephedrine—Insomnia—Estropipate—osteoporosis	0.00339	0.0039	CcSEcCtD
Ephedrine—Tension—Pamidronate—osteoporosis	0.00339	0.0039	CcSEcCtD
Ephedrine—Anorexia—Calcitriol—osteoporosis	0.00336	0.00386	CcSEcCtD
Ephedrine—Nervousness—Pamidronate—osteoporosis	0.00336	0.00386	CcSEcCtD
Ephedrine—Muscle spasms—Pamidronate—osteoporosis	0.00332	0.00382	CcSEcCtD
Ephedrine—Dyspepsia—Estropipate—osteoporosis	0.0033	0.0038	CcSEcCtD
Ephedrine—Insomnia—Raloxifene—osteoporosis	0.00329	0.00378	CcSEcCtD
Ephedrine—Vertigo—Risedronate—osteoporosis	0.00327	0.00376	CcSEcCtD
Ephedrine—Insomnia—Ibandronate—osteoporosis	0.00326	0.00374	CcSEcCtD
Ephedrine—Dyspepsia—Alendronate—osteoporosis	0.00325	0.00374	CcSEcCtD
Ephedrine—Arrhythmia—Zoledronate—osteoporosis	0.00324	0.00373	CcSEcCtD
Ephedrine—Pain—Estropipate—osteoporosis	0.00321	0.00369	CcSEcCtD
Ephedrine—Dyspepsia—Raloxifene—osteoporosis	0.0032	0.00368	CcSEcCtD
Ephedrine—Insomnia—Calcitriol—osteoporosis	0.00319	0.00367	CcSEcCtD
Ephedrine—Agitation—Pamidronate—osteoporosis	0.00317	0.00365	CcSEcCtD
Ephedrine—Dyspepsia—Ibandronate—osteoporosis	0.00317	0.00364	CcSEcCtD
Ephedrine—Anxiety—Ethinyl Estradiol—osteoporosis	0.00316	0.00364	CcSEcCtD
Ephedrine—Pain—Alendronate—osteoporosis	0.00316	0.00364	CcSEcCtD
Ephedrine—Hypertension—Risedronate—osteoporosis	0.00314	0.00361	CcSEcCtD
Ephedrine—Decreased appetite—Ibandronate—osteoporosis	0.00313	0.0036	CcSEcCtD
Ephedrine—Arrhythmia—Conjugated Estrogens—osteoporosis	0.00312	0.00359	CcSEcCtD
Ephedrine—Pain—Raloxifene—osteoporosis	0.00311	0.00358	CcSEcCtD
Ephedrine—Chest pain—Risedronate—osteoporosis	0.00309	0.00356	CcSEcCtD
Ephedrine—Anxiety—Risedronate—osteoporosis	0.00308	0.00355	CcSEcCtD
Ephedrine—Pain—Ibandronate—osteoporosis	0.00308	0.00354	CcSEcCtD
Ephedrine—Decreased appetite—Calcitriol—osteoporosis	0.00306	0.00352	CcSEcCtD
Ephedrine—Feeling abnormal—Alendronate—osteoporosis	0.00305	0.0035	CcSEcCtD
Ephedrine—Muscle spasms—Zoledronate—osteoporosis	0.00303	0.00349	CcSEcCtD
Ephedrine—Pain—Calcitriol—osteoporosis	0.00301	0.00347	CcSEcCtD
Ephedrine—Hypertension—Pamidronate—osteoporosis	0.00298	0.00343	CcSEcCtD
Ephedrine—Tension—Conjugated Estrogens—osteoporosis	0.00298	0.00343	CcSEcCtD
Ephedrine—Body temperature increased—Estropipate—osteoporosis	0.00297	0.00341	CcSEcCtD
Ephedrine—Feeling abnormal—Ibandronate—osteoporosis	0.00297	0.00341	CcSEcCtD
Ephedrine—Tremor—Zoledronate—osteoporosis	0.00296	0.0034	CcSEcCtD
Ephedrine—Pseudoephedrine—TNF—osteoporosis	0.00295	0.0884	CrCbGaD
Ephedrine—Nervousness—Conjugated Estrogens—osteoporosis	0.00295	0.00339	CcSEcCtD
Ephedrine—Anxiety—Pamidronate—osteoporosis	0.00293	0.00337	CcSEcCtD
Ephedrine—Body temperature increased—Alendronate—osteoporosis	0.00292	0.00336	CcSEcCtD
Ephedrine—Muscle spasms—Conjugated Estrogens—osteoporosis	0.00292	0.00336	CcSEcCtD
Ephedrine—Agitation—Zoledronate—osteoporosis	0.0029	0.00334	CcSEcCtD
Ephedrine—Body temperature increased—Raloxifene—osteoporosis	0.00287	0.00331	CcSEcCtD
Ephedrine—Body temperature increased—Ibandronate—osteoporosis	0.00285	0.00327	CcSEcCtD
Ephedrine—Confusional state—Pamidronate—osteoporosis	0.00284	0.00327	CcSEcCtD
Ephedrine—Vertigo—Zoledronate—osteoporosis	0.00284	0.00326	CcSEcCtD
Ephedrine—Palpitations—Zoledronate—osteoporosis	0.00279	0.00321	CcSEcCtD
Ephedrine—Body temperature increased—Calcitriol—osteoporosis	0.00279	0.0032	CcSEcCtD
Ephedrine—Vomiting—Etidronic acid—osteoporosis	0.00276	0.00317	CcSEcCtD
Ephedrine—Tachycardia—Pamidronate—osteoporosis	0.00275	0.00317	CcSEcCtD
Ephedrine—Rash—Etidronic acid—osteoporosis	0.00274	0.00315	CcSEcCtD
Ephedrine—Dermatitis—Etidronic acid—osteoporosis	0.00273	0.00314	CcSEcCtD
Ephedrine—Vertigo—Conjugated Estrogens—osteoporosis	0.00273	0.00314	CcSEcCtD
Ephedrine—Hyperhidrosis—Pamidronate—osteoporosis	0.00273	0.00314	CcSEcCtD
Ephedrine—Hypertension—Zoledronate—osteoporosis	0.00272	0.00313	CcSEcCtD
Ephedrine—Headache—Etidronic acid—osteoporosis	0.00272	0.00313	CcSEcCtD
Ephedrine—Asthenia—Estropipate—osteoporosis	0.00269	0.0031	CcSEcCtD
Ephedrine—Anorexia—Pamidronate—osteoporosis	0.00269	0.00309	CcSEcCtD
Ephedrine—Chest pain—Zoledronate—osteoporosis	0.00269	0.00309	CcSEcCtD
Ephedrine—Palpitations—Conjugated Estrogens—osteoporosis	0.00269	0.00309	CcSEcCtD
Ephedrine—Insomnia—Risedronate—osteoporosis	0.00268	0.00309	CcSEcCtD
Ephedrine—Anxiety—Zoledronate—osteoporosis	0.00268	0.00308	CcSEcCtD
Ephedrine—Asthenia—Alendronate—osteoporosis	0.00265	0.00305	CcSEcCtD
Ephedrine—Dyspnoea—Risedronate—osteoporosis	0.00264	0.00304	CcSEcCtD
Ephedrine—Dyspepsia—Risedronate—osteoporosis	0.00261	0.003	CcSEcCtD
Ephedrine—Confusional state—Zoledronate—osteoporosis	0.0026	0.00299	CcSEcCtD
Ephedrine—Chest pain—Conjugated Estrogens—osteoporosis	0.00259	0.00298	CcSEcCtD
Ephedrine—Asthenia—Ibandronate—osteoporosis	0.00258	0.00297	CcSEcCtD
Ephedrine—Anxiety—Conjugated Estrogens—osteoporosis	0.00258	0.00297	CcSEcCtD
Ephedrine—Nausea—Etidronic acid—osteoporosis	0.00258	0.00296	CcSEcCtD
Ephedrine—Insomnia—Pamidronate—osteoporosis	0.00255	0.00293	CcSEcCtD
Ephedrine—Pain—Risedronate—osteoporosis	0.00254	0.00292	CcSEcCtD
Ephedrine—Asthenia—Calcitriol—osteoporosis	0.00253	0.00291	CcSEcCtD
Ephedrine—Dyspnoea—Pamidronate—osteoporosis	0.00251	0.00289	CcSEcCtD
Ephedrine—Tachycardia—Zoledronate—osteoporosis	0.00251	0.00289	CcSEcCtD
Ephedrine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.00251	0.00288	CcSEcCtD
Ephedrine—Hyperhidrosis—Zoledronate—osteoporosis	0.00249	0.00286	CcSEcCtD
Ephedrine—Dyspepsia—Pamidronate—osteoporosis	0.00248	0.00285	CcSEcCtD
Ephedrine—Dizziness—Estropipate—osteoporosis	0.00248	0.00285	CcSEcCtD
Ephedrine—Anorexia—Zoledronate—osteoporosis	0.00245	0.00282	CcSEcCtD
Ephedrine—Decreased appetite—Pamidronate—osteoporosis	0.00245	0.00282	CcSEcCtD
Ephedrine—Dizziness—Alendronate—osteoporosis	0.00244	0.00281	CcSEcCtD
Ephedrine—Tachycardia—Conjugated Estrogens—osteoporosis	0.00242	0.00278	CcSEcCtD
Ephedrine—Pain—Pamidronate—osteoporosis	0.00241	0.00277	CcSEcCtD
Ephedrine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.0024	0.00277	CcSEcCtD
Ephedrine—Dizziness—Raloxifene—osteoporosis	0.0024	0.00277	CcSEcCtD
Ephedrine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.0024	0.00276	CcSEcCtD
Ephedrine—Tension—Estradiol—osteoporosis	0.00239	0.00275	CcSEcCtD
Ephedrine—Vomiting—Estropipate—osteoporosis	0.00239	0.00274	CcSEcCtD
Ephedrine—Dizziness—Ibandronate—osteoporosis	0.00238	0.00274	CcSEcCtD
Ephedrine—Rash—Estropipate—osteoporosis	0.00237	0.00272	CcSEcCtD
Ephedrine—Dermatitis—Estropipate—osteoporosis	0.00236	0.00272	CcSEcCtD
Ephedrine—Anorexia—Conjugated Estrogens—osteoporosis	0.00236	0.00272	CcSEcCtD
Ephedrine—Nervousness—Estradiol—osteoporosis	0.00236	0.00272	CcSEcCtD
Ephedrine—Headache—Estropipate—osteoporosis	0.00235	0.0027	CcSEcCtD
Ephedrine—Vomiting—Alendronate—osteoporosis	0.00235	0.0027	CcSEcCtD
Ephedrine—Body temperature increased—Risedronate—osteoporosis	0.00234	0.0027	CcSEcCtD
Ephedrine—Muscle spasms—Estradiol—osteoporosis	0.00234	0.00269	CcSEcCtD
Ephedrine—Rash—Alendronate—osteoporosis	0.00233	0.00268	CcSEcCtD
Ephedrine—Insomnia—Zoledronate—osteoporosis	0.00233	0.00268	CcSEcCtD
Ephedrine—Dermatitis—Alendronate—osteoporosis	0.00233	0.00268	CcSEcCtD
Ephedrine—Feeling abnormal—Pamidronate—osteoporosis	0.00232	0.00267	CcSEcCtD
Ephedrine—Headache—Alendronate—osteoporosis	0.00232	0.00266	CcSEcCtD
Ephedrine—Vomiting—Raloxifene—osteoporosis	0.00231	0.00266	CcSEcCtD
Ephedrine—Dyspnoea—Zoledronate—osteoporosis	0.0023	0.00264	CcSEcCtD
Ephedrine—Rash—Raloxifene—osteoporosis	0.00229	0.00264	CcSEcCtD
Ephedrine—Dermatitis—Raloxifene—osteoporosis	0.00229	0.00263	CcSEcCtD
Ephedrine—Vomiting—Ibandronate—osteoporosis	0.00229	0.00263	CcSEcCtD
Ephedrine—Tremor—Estradiol—osteoporosis	0.00228	0.00262	CcSEcCtD
Ephedrine—Headache—Raloxifene—osteoporosis	0.00228	0.00262	CcSEcCtD
Ephedrine—Rash—Ibandronate—osteoporosis	0.00227	0.00261	CcSEcCtD
Ephedrine—Dermatitis—Ibandronate—osteoporosis	0.00227	0.00261	CcSEcCtD
Ephedrine—Dyspepsia—Zoledronate—osteoporosis	0.00227	0.00261	CcSEcCtD
Ephedrine—Headache—Ibandronate—osteoporosis	0.00225	0.00259	CcSEcCtD
Ephedrine—Insomnia—Conjugated Estrogens—osteoporosis	0.00224	0.00258	CcSEcCtD
Ephedrine—Vomiting—Calcitriol—osteoporosis	0.00224	0.00258	CcSEcCtD
Ephedrine—Decreased appetite—Zoledronate—osteoporosis	0.00224	0.00258	CcSEcCtD
Ephedrine—Agitation—Estradiol—osteoporosis	0.00223	0.00257	CcSEcCtD
Ephedrine—Nausea—Estropipate—osteoporosis	0.00223	0.00256	CcSEcCtD
Ephedrine—Body temperature increased—Pamidronate—osteoporosis	0.00223	0.00256	CcSEcCtD
Ephedrine—Rash—Calcitriol—osteoporosis	0.00222	0.00256	CcSEcCtD
Ephedrine—Dermatitis—Calcitriol—osteoporosis	0.00222	0.00255	CcSEcCtD
Ephedrine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.00221	0.00254	CcSEcCtD
Ephedrine—Headache—Calcitriol—osteoporosis	0.00221	0.00254	CcSEcCtD
Ephedrine—Pain—Zoledronate—osteoporosis	0.0022	0.00253	CcSEcCtD
Ephedrine—Nausea—Alendronate—osteoporosis	0.0022	0.00253	CcSEcCtD
Ephedrine—Vertigo—Estradiol—osteoporosis	0.00218	0.00251	CcSEcCtD
Ephedrine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.00218	0.00251	CcSEcCtD
Ephedrine—Asthenia—Ethinyl Estradiol—osteoporosis	0.00218	0.00251	CcSEcCtD
Ephedrine—Nausea—Raloxifene—osteoporosis	0.00216	0.00248	CcSEcCtD
Ephedrine—Decreased appetite—Conjugated Estrogens—osteoporosis	0.00216	0.00248	CcSEcCtD
Ephedrine—Palpitations—Estradiol—osteoporosis	0.00215	0.00247	CcSEcCtD
Ephedrine—Nausea—Ibandronate—osteoporosis	0.00214	0.00246	CcSEcCtD
Ephedrine—Asthenia—Risedronate—osteoporosis	0.00213	0.00245	CcSEcCtD
Ephedrine—Feeling abnormal—Zoledronate—osteoporosis	0.00212	0.00244	CcSEcCtD
Ephedrine—Pain—Conjugated Estrogens—osteoporosis	0.00212	0.00244	CcSEcCtD
Ephedrine—Hypertension—Estradiol—osteoporosis	0.0021	0.00242	CcSEcCtD
Ephedrine—Nausea—Calcitriol—osteoporosis	0.00209	0.00241	CcSEcCtD
Ephedrine—Chest pain—Estradiol—osteoporosis	0.00207	0.00238	CcSEcCtD
Ephedrine—Anxiety—Estradiol—osteoporosis	0.00206	0.00237	CcSEcCtD
Ephedrine—Body temperature increased—Zoledronate—osteoporosis	0.00204	0.00234	CcSEcCtD
Ephedrine—Asthenia—Pamidronate—osteoporosis	0.00202	0.00233	CcSEcCtD
Ephedrine—Dizziness—Ethinyl Estradiol—osteoporosis	0.00201	0.00231	CcSEcCtD
Ephedrine—Confusional state—Estradiol—osteoporosis	0.002	0.0023	CcSEcCtD
Ephedrine—Dizziness—Risedronate—osteoporosis	0.00196	0.00226	CcSEcCtD
Ephedrine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.00196	0.00226	CcSEcCtD
Ephedrine—Tachycardia—Estradiol—osteoporosis	0.00194	0.00223	CcSEcCtD
Ephedrine—Vomiting—Ethinyl Estradiol—osteoporosis	0.00193	0.00222	CcSEcCtD
Ephedrine—Hyperhidrosis—Estradiol—osteoporosis	0.00192	0.00221	CcSEcCtD
Ephedrine—Rash—Ethinyl Estradiol—osteoporosis	0.00192	0.00221	CcSEcCtD
Ephedrine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00192	0.0022	CcSEcCtD
Ephedrine—Headache—Ethinyl Estradiol—osteoporosis	0.00191	0.00219	CcSEcCtD
Ephedrine—Vomiting—Risedronate—osteoporosis	0.00189	0.00217	CcSEcCtD
Ephedrine—Rash—Risedronate—osteoporosis	0.00187	0.00215	CcSEcCtD
Ephedrine—Dermatitis—Risedronate—osteoporosis	0.00187	0.00215	CcSEcCtD
Ephedrine—Dizziness—Pamidronate—osteoporosis	0.00186	0.00214	CcSEcCtD
Ephedrine—Headache—Risedronate—osteoporosis	0.00186	0.00214	CcSEcCtD
Ephedrine—Asthenia—Zoledronate—osteoporosis	0.00185	0.00213	CcSEcCtD
Ephedrine—Nausea—Ethinyl Estradiol—osteoporosis	0.00181	0.00208	CcSEcCtD
Ephedrine—Insomnia—Estradiol—osteoporosis	0.0018	0.00206	CcSEcCtD
Ephedrine—Vomiting—Pamidronate—osteoporosis	0.00179	0.00206	CcSEcCtD
Ephedrine—Asthenia—Conjugated Estrogens—osteoporosis	0.00178	0.00205	CcSEcCtD
Ephedrine—Rash—Pamidronate—osteoporosis	0.00178	0.00204	CcSEcCtD
Ephedrine—Dermatitis—Pamidronate—osteoporosis	0.00178	0.00204	CcSEcCtD
Ephedrine—Dyspnoea—Estradiol—osteoporosis	0.00177	0.00204	CcSEcCtD
Ephedrine—Headache—Pamidronate—osteoporosis	0.00177	0.00203	CcSEcCtD
Ephedrine—Nausea—Risedronate—osteoporosis	0.00176	0.00203	CcSEcCtD
Ephedrine—Dyspepsia—Estradiol—osteoporosis	0.00175	0.00201	CcSEcCtD
Ephedrine—Decreased appetite—Estradiol—osteoporosis	0.00173	0.00198	CcSEcCtD
Ephedrine—Dizziness—Zoledronate—osteoporosis	0.0017	0.00196	CcSEcCtD
Ephedrine—Pain—Estradiol—osteoporosis	0.0017	0.00195	CcSEcCtD
Ephedrine—Nausea—Pamidronate—osteoporosis	0.00167	0.00193	CcSEcCtD
Ephedrine—Dizziness—Conjugated Estrogens—osteoporosis	0.00164	0.00189	CcSEcCtD
Ephedrine—Vomiting—Zoledronate—osteoporosis	0.00164	0.00188	CcSEcCtD
Ephedrine—Feeling abnormal—Estradiol—osteoporosis	0.00164	0.00188	CcSEcCtD
Ephedrine—Rash—Zoledronate—osteoporosis	0.00162	0.00187	CcSEcCtD
Ephedrine—Dermatitis—Zoledronate—osteoporosis	0.00162	0.00187	CcSEcCtD
Ephedrine—Headache—Zoledronate—osteoporosis	0.00161	0.00186	CcSEcCtD
Ephedrine—Vomiting—Conjugated Estrogens—osteoporosis	0.00158	0.00181	CcSEcCtD
Ephedrine—Body temperature increased—Estradiol—osteoporosis	0.00157	0.0018	CcSEcCtD
Ephedrine—Rash—Conjugated Estrogens—osteoporosis	0.00156	0.0018	CcSEcCtD
Ephedrine—Dermatitis—Conjugated Estrogens—osteoporosis	0.00156	0.0018	CcSEcCtD
Ephedrine—Headache—Conjugated Estrogens—osteoporosis	0.00155	0.00179	CcSEcCtD
Ephedrine—Nausea—Zoledronate—osteoporosis	0.00153	0.00176	CcSEcCtD
Ephedrine—Nausea—Conjugated Estrogens—osteoporosis	0.00147	0.00169	CcSEcCtD
Ephedrine—Asthenia—Estradiol—osteoporosis	0.00142	0.00164	CcSEcCtD
Ephedrine—Dizziness—Estradiol—osteoporosis	0.00131	0.00151	CcSEcCtD
Ephedrine—Vomiting—Estradiol—osteoporosis	0.00126	0.00145	CcSEcCtD
Ephedrine—Rash—Estradiol—osteoporosis	0.00125	0.00144	CcSEcCtD
Ephedrine—Dermatitis—Estradiol—osteoporosis	0.00125	0.00144	CcSEcCtD
Ephedrine—Headache—Estradiol—osteoporosis	0.00124	0.00143	CcSEcCtD
Ephedrine—Nausea—Estradiol—osteoporosis	0.00118	0.00136	CcSEcCtD
Ephedrine—ACHE—Monoamine Transport—TNF—osteoporosis	0.000633	0.00651	CbGpPWpGaD
Ephedrine—ACHE—Peptide hormone metabolism—LEP—osteoporosis	0.000626	0.00644	CbGpPWpGaD
Ephedrine—SLC6A2—Monoamine Transport—TNF—osteoporosis	0.000626	0.00643	CbGpPWpGaD
Ephedrine—ADRB2—G alpha (s) signalling events—CALCA—osteoporosis	0.000623	0.0064	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000615	0.00632	CbGpPWpGaD
Ephedrine—SLC18A2—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000595	0.00612	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—CALCR—osteoporosis	0.00059	0.00606	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—PTH1R—osteoporosis	0.00059	0.00606	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000578	0.00595	CbGpPWpGaD
Ephedrine—BCHE—Peptide hormone metabolism—LEP—osteoporosis	0.000559	0.00574	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000548	0.00564	CbGpPWpGaD
Ephedrine—SLC18A2—Transmission across Chemical Synapses—ADCY5—osteoporosis	0.000542	0.00557	CbGpPWpGaD
Ephedrine—ACHE—Peptide hormone metabolism—POMC—osteoporosis	0.000538	0.00553	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—CCT2—osteoporosis	0.000531	0.00546	CbGpPWpGaD
Ephedrine—ACHE—Peptide hormone metabolism—IGF1—osteoporosis	0.000517	0.00532	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	0.000516	0.0053	CbGpPWpGaD
Ephedrine—ADRA1A—AMPK Signaling—LEP—osteoporosis	0.000501	0.00515	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—CALCR—osteoporosis	0.000488	0.00502	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—PTH1R—osteoporosis	0.000488	0.00502	CbGpPWpGaD
Ephedrine—BCHE—Peptide hormone metabolism—POMC—osteoporosis	0.00048	0.00493	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000478	0.00491	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—CCT2—osteoporosis	0.000474	0.00487	CbGpPWpGaD
Ephedrine—SLC6A2—NRF2 pathway—AGER—osteoporosis	0.000471	0.00484	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000466	0.00479	CbGpPWpGaD
Ephedrine—ADRB2—GPCRs, Class A Rhodopsin-like—CNR2—osteoporosis	0.000463	0.00476	CbGpPWpGaD
Ephedrine—BCHE—Peptide hormone metabolism—IGF1—osteoporosis	0.000462	0.00475	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—TUBA1B—osteoporosis	0.000451	0.00464	CbGpPWpGaD
Ephedrine—ADRB2—G alpha (s) signalling events—ADCY5—osteoporosis	0.000443	0.00455	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000426	0.00438	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000415	0.00427	CbGpPWpGaD
Ephedrine—SLC18A2—Neuronal System—ADCY5—osteoporosis	0.000415	0.00427	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—TUBA1B—osteoporosis	0.000403	0.00414	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.0004	0.00412	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	0.000397	0.00408	CbGpPWpGaD
Ephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—CNR2—osteoporosis	0.000383	0.00394	CbGpPWpGaD
Ephedrine—ADRB2—Calcium Regulation in the Cardiac Cell—ADCY5—osteoporosis	0.000382	0.00393	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000372	0.00383	CbGpPWpGaD
Ephedrine—ACHE—Transmission across Chemical Synapses—ADCY5—osteoporosis	0.000369	0.00379	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—RPL24—osteoporosis	0.000361	0.00371	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—CALCR—osteoporosis	0.000333	0.00343	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PTH1R—osteoporosis	0.000333	0.00343	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000332	0.00341	CbGpPWpGaD
Ephedrine—BCHE—Transmission across Chemical Synapses—ADCY5—osteoporosis	0.000329	0.00338	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	0.000328	0.00337	CbGpPWpGaD
Ephedrine—ADRB2—G alpha (s) signalling events—POMC—osteoporosis	0.000326	0.00335	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—RPL24—osteoporosis	0.000322	0.00331	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—TLN1—osteoporosis	0.000317	0.00326	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000317	0.00325	CbGpPWpGaD
Ephedrine—ADRA1A—Calcium Regulation in the Cardiac Cell—ADCY5—osteoporosis	0.000316	0.00325	CbGpPWpGaD
Ephedrine—ACHE—ATF-2 transcription factor network—IL6—osteoporosis	0.000313	0.00322	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	0.000313	0.00322	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—PTH—osteoporosis	0.00031	0.00319	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—REN—osteoporosis	0.000305	0.00314	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PTH1R—osteoporosis	0.000303	0.00311	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—CALCR—osteoporosis	0.000303	0.00311	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—CNR2—osteoporosis	0.000302	0.0031	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PKM—osteoporosis	0.000289	0.00297	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—FDPS—osteoporosis	0.000289	0.00297	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—WNT1—osteoporosis	0.000284	0.00292	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—TLN1—osteoporosis	0.000283	0.00291	CbGpPWpGaD
Ephedrine—ACHE—Neuronal System—ADCY5—osteoporosis	0.000283	0.00291	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000282	0.0029	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—CALCR—osteoporosis	0.000276	0.00283	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PTH1R—osteoporosis	0.000276	0.00283	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PGLS—osteoporosis	0.000274	0.00281	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—GPD2—osteoporosis	0.000274	0.00281	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—REN—osteoporosis	0.000272	0.0028	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	0.000271	0.00278	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—MGLL—osteoporosis	0.000265	0.00272	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PKM—osteoporosis	0.000258	0.00265	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—FDPS—osteoporosis	0.000258	0.00265	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—PTHLH—osteoporosis	0.000257	0.00264	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—PTH—osteoporosis	0.000256	0.00263	CbGpPWpGaD
Ephedrine—BCHE—Neuronal System—ADCY5—osteoporosis	0.000252	0.00259	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PTH1R—osteoporosis	0.00025	0.00257	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—CALCR—osteoporosis	0.00025	0.00257	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—ATIC—osteoporosis	0.00025	0.00257	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PNP—osteoporosis	0.00025	0.00257	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—CNR2—osteoporosis	0.00025	0.00257	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PGLS—osteoporosis	0.000244	0.00251	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GPD2—osteoporosis	0.000244	0.00251	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—MGLL—osteoporosis	0.00024	0.00247	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—WNT1—osteoporosis	0.000235	0.00241	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—CALCA—osteoporosis	0.000226	0.00232	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—ATIC—osteoporosis	0.000223	0.0023	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PNP—osteoporosis	0.000223	0.0023	CbGpPWpGaD
Ephedrine—SLC18A2—Transmembrane transport of small molecules—ADCY5—osteoporosis	0.000223	0.00229	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—MGLL—osteoporosis	0.000219	0.00225	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—CA2—osteoporosis	0.000213	0.00219	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—OXCT1—osteoporosis	0.000213	0.00219	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—PTHLH—osteoporosis	0.000212	0.00218	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—MGLL—osteoporosis	0.000207	0.00213	CbGpPWpGaD
Ephedrine—SLC6A2—NRF2 pathway—TGFB1—osteoporosis	0.000199	0.00205	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—MGLL—osteoporosis	0.000199	0.00204	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—SOST—osteoporosis	0.000198	0.00203	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	0.000196	0.00201	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—ACE—osteoporosis	0.00019	0.00196	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—OXCT1—osteoporosis	0.00019	0.00195	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CA2—osteoporosis	0.00019	0.00195	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—CALCA—osteoporosis	0.000187	0.00192	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—MGLL—osteoporosis	0.000185	0.0019	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CALCR—osteoporosis	0.000179	0.00184	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PTH1R—osteoporosis	0.000179	0.00184	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—IDH2—osteoporosis	0.000176	0.00181	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PTH—osteoporosis	0.000175	0.0018	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	0.000174	0.00179	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—CNR2—osteoporosis	0.000171	0.00175	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—ACE—osteoporosis	0.00017	0.00175	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	0.000169	0.00174	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—CYP27A1—osteoporosis	0.000166	0.0017	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SOST—osteoporosis	0.000164	0.00168	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	0.000163	0.00167	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	0.000162	0.00167	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—ACP5—osteoporosis	0.000161	0.00166	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	0.000159	0.00164	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PTH—osteoporosis	0.000159	0.00163	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—IDH2—osteoporosis	0.000157	0.00162	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000155	0.0016	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—CNR2—osteoporosis	0.000155	0.00159	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	0.000152	0.00156	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—ADCY5—osteoporosis	0.00015	0.00154	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—TPI1—osteoporosis	0.00015	0.00154	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CYP27A1—osteoporosis	0.000148	0.00152	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PTH1R—osteoporosis	0.000148	0.00152	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CALCR—osteoporosis	0.000148	0.00152	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—WNT1—osteoporosis	0.000146	0.0015	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PTHLH—osteoporosis	0.000145	0.00149	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PTH—osteoporosis	0.000145	0.00149	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—ACP5—osteoporosis	0.000144	0.00148	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	0.000142	0.00146	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MGLL—osteoporosis	0.000142	0.00146	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—CNR2—osteoporosis	0.000141	0.00145	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—P4HB—osteoporosis	0.000141	0.00145	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—LRP5—osteoporosis	0.000139	0.00143	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—GAPDH—osteoporosis	0.000138	0.00142	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—RAP1A—osteoporosis	0.000135	0.00139	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—TPI1—osteoporosis	0.000134	0.00138	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—LRP6—osteoporosis	0.000133	0.00136	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PTHLH—osteoporosis	0.000132	0.00135	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PTH—osteoporosis	0.000132	0.00135	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000128	0.00132	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—CNR2—osteoporosis	0.000128	0.00132	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—CALCA—osteoporosis	0.000128	0.00131	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—P4HB—osteoporosis	0.000126	0.00129	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GAPDH—osteoporosis	0.000123	0.00127	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—WNT1—osteoporosis	0.000121	0.00124	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—RAP1A—osteoporosis	0.00012	0.00124	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PTHLH—osteoporosis	0.00012	0.00123	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—POMC—osteoporosis	0.000118	0.00122	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—LEP—osteoporosis	0.000118	0.00122	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—POMC—osteoporosis	0.000118	0.00121	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MGLL—osteoporosis	0.000117	0.00121	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—CALCA—osteoporosis	0.000116	0.00119	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—LRP5—osteoporosis	0.000115	0.00118	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TLN1—osteoporosis	0.000112	0.00115	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—LRP6—osteoporosis	0.00011	0.00113	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PTHLH—osteoporosis	0.000109	0.00112	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—ENO1—osteoporosis	0.000109	0.00112	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PSMA2—osteoporosis	0.000107	0.0011	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PSMA5—osteoporosis	0.000107	0.0011	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—CALCA—osteoporosis	0.000106	0.00109	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—LEP—osteoporosis	0.000105	0.00108	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—POMC—osteoporosis	0.000105	0.00108	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—POMC—osteoporosis	0.000102	0.00104	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—POMC—osteoporosis	9.78e-05	0.00101	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—IGF1—osteoporosis	9.77e-05	0.001	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—ENO1—osteoporosis	9.72e-05	0.000999	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—P4HB—osteoporosis	9.66e-05	0.000993	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—CALCA—osteoporosis	9.59e-05	0.000986	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PSMA5—osteoporosis	9.58e-05	0.000985	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PSMA2—osteoporosis	9.58e-05	0.000985	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PTH—osteoporosis	9.39e-05	0.000966	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TLN1—osteoporosis	9.26e-05	0.000952	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—RAP1A—osteoporosis	9.23e-05	0.000949	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CNR2—osteoporosis	9.15e-05	0.000941	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—ADCY5—osteoporosis	9.09e-05	0.000934	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—POMC—osteoporosis	9.06e-05	0.000931	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NFATC1—osteoporosis	9.01e-05	0.000926	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—DKK1—osteoporosis	8.93e-05	0.000918	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—IGF1—osteoporosis	8.72e-05	0.000896	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—CYP19A1—osteoporosis	8.71e-05	0.000895	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—WNT1—osteoporosis	8.61e-05	0.000885	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—FGA—osteoporosis	8.37e-05	0.000861	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—ADCY5—osteoporosis	8.25e-05	0.000848	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—P4HB—osteoporosis	7.99e-05	0.000821	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PTHLH—osteoporosis	7.78e-05	0.0008	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—BMP2—osteoporosis	7.78e-05	0.0008	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CYP19A1—osteoporosis	7.77e-05	0.000799	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PTH—osteoporosis	7.77e-05	0.000799	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—RAP1A—osteoporosis	7.64e-05	0.000785	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—FGB—osteoporosis	7.62e-05	0.000783	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CNR2—osteoporosis	7.57e-05	0.000778	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	7.54e-05	0.000775	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—ADCY5—osteoporosis	7.52e-05	0.000773	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NFATC1—osteoporosis	7.45e-05	0.000766	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—DKK1—osteoporosis	7.39e-05	0.00076	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PSMA2—osteoporosis	7.35e-05	0.000756	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PSMA5—osteoporosis	7.35e-05	0.000756	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—WNT1—osteoporosis	7.12e-05	0.000732	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—ADCY5—osteoporosis	7.12e-05	0.000732	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—GPX1—osteoporosis	7.09e-05	0.000729	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—FGA—osteoporosis	6.92e-05	0.000712	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CALCA—osteoporosis	6.85e-05	0.000704	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—ADCY5—osteoporosis	6.82e-05	0.000702	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—POMC—osteoporosis	6.68e-05	0.000687	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—MTHFR—osteoporosis	6.55e-05	0.000673	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PTHLH—osteoporosis	6.44e-05	0.000662	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—BMP2—osteoporosis	6.44e-05	0.000662	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—ADCY5—osteoporosis	6.35e-05	0.000653	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GPX1—osteoporosis	6.33e-05	0.00065	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—FGB—osteoporosis	6.3e-05	0.000648	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—KL—osteoporosis	6.22e-05	0.00064	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PSMA2—osteoporosis	6.08e-05	0.000625	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PSMA5—osteoporosis	6.08e-05	0.000625	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—POMC—osteoporosis	6.07e-05	0.000624	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—IL6R—osteoporosis	5.92e-05	0.000609	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—MTHFR—osteoporosis	5.84e-05	0.0006	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CALCA—osteoporosis	5.67e-05	0.000583	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—POMC—osteoporosis	5.53e-05	0.000568	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—POMC—osteoporosis	5.23e-05	0.000538	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—KL—osteoporosis	5.15e-05	0.000529	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—POMC—osteoporosis	5.02e-05	0.000516	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—IL6R—osteoporosis	4.9e-05	0.000503	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—ADCY5—osteoporosis	4.87e-05	0.000501	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—SPP1—osteoporosis	4.72e-05	0.000485	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—POMC—osteoporosis	4.67e-05	0.00048	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IRS2—osteoporosis	4.26e-05	0.000438	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—LEP—osteoporosis	4.17e-05	0.000429	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ADCY5—osteoporosis	4.03e-05	0.000414	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—ESR1—osteoporosis	3.98e-05	0.00041	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SPP1—osteoporosis	3.9e-05	0.000401	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IRS1—osteoporosis	3.72e-05	0.000383	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—POMC—osteoporosis	3.59e-05	0.000369	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IRS2—osteoporosis	3.53e-05	0.000363	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IL6R—osteoporosis	3.5e-05	0.00036	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—LEP—osteoporosis	3.45e-05	0.000355	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IGF1—osteoporosis	3.45e-05	0.000355	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ESR1—osteoporosis	3.3e-05	0.000339	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IRS1—osteoporosis	3.08e-05	0.000317	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—POMC—osteoporosis	2.97e-05	0.000305	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IL6R—osteoporosis	2.89e-05	0.000297	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IGF1—osteoporosis	2.85e-05	0.000293	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—IL6—osteoporosis	2.64e-05	0.000271	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—IL6—osteoporosis	2.18e-05	0.000224	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MYC—osteoporosis	2.07e-05	0.000213	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TGFB1—osteoporosis	2.07e-05	0.000213	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MYC—osteoporosis	1.71e-05	0.000176	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TGFB1—osteoporosis	1.71e-05	0.000176	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IL6—osteoporosis	1.56e-05	0.00016	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IL6—osteoporosis	1.29e-05	0.000132	CbGpPWpGaD
